Table 4 Exploratory analysis of chemotherapy classes as risk factors for CDI.
Risk factor for CDI-Chemotherapy classes | Odds ratio | 95% CI | p-value |
|---|---|---|---|
Platinum drugs | OR = 0.55 | 0.27–1.10 | p = 0.091 |
Topoisomerase inhibitors | OR = 0.59 | 0.30–1.17 | p = 0.133 |
Anthracyclines | OR = 0.52 | 0.27–1.02 | p = 0.056 |
Taxanes | OR = 0.42 | 0.15–1.18 | p = 0.100 |